Pulmonx Corporation
USD1.61
+0.02 (+1.26%)
CEO
Glendon E. French
IPO Date
2020-10-01
Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Country
US
Open
$1.57
Prev. Close
$1.59
Day Low
$1.57
Day High
$1.65
52W Low
$1.13
52W High
$3.88
Market Cap
$0.07B
Volume
0.19M
| 2,461 |
| $1.43 |
| 4 Mar 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | S-Sale | Disposed | 756 | $1.43 |
| 4 Mar 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | S-Sale | Disposed | 4,198 | $1.43 |
| 4 Mar 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | A-Award | Acquired | 175,000 | $0.00 |
| 4 Mar 2026 | French Glendon E. III | director, officer: President and CEO | S-Sale | Disposed | 2,708 | $1.43 |
| 4 Mar 2026 | French Glendon E. III | director, officer: President and CEO | S-Sale | Disposed | 6,737 | $1.43 |
| 4 Mar 2026 | French Glendon E. III | director, officer: President and CEO | S-Sale | Disposed | 58,368 | $1.43 |
| 4 Mar 2026 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | S-Sale | Disposed | 2,125 | $1.43 |
| 4 Mar 2026 | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | S-Sale | Disposed | 1,861 | $1.43 |